Mar 17, 2022 3:00am EDT NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer
Mar 02, 2022 4:05pm EST NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
Feb 23, 2022 7:00am EST NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
Feb 14, 2022 7:00am EST NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer